NIH-funded research NIH-funded research

Understanding how telomerase affects aging and cancer

Official title: Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body

Funded at Research Inst of Fox Chase Can Ctr · NIH-11089589 · Data updated 2026-11-12

This study is looking at how an enzyme called telomerase helps keep our cells healthy and young, which could lead to new treatments for age-related diseases and cancer, so it's especially for anyone interested in understanding how we can fight these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionResearch Inst of Fox Chase Can Ctr
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endMay 31, 2028
Funding year2025
Award (this year)$470,000
NIH project number5R35GM150538-03
Project IDNIH-11089589 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing age-related health issues or those diagnosed with cancers that exploit telomerase for growth.

Less likely to help

Patients with conditions unrelated to telomere dysfunction or those not affected by aging or cancer may not benefit from this research.

What this research studies

This research investigates the role of the enzyme telomerase in maintaining telomere length, which is crucial for cellular aging and cancer development. By exploring how telomerase can be modulated, the study aims to uncover mechanisms that lead to either aging-related diseases or cancer growth. The approach includes advanced techniques like next-generation RNA structural profiling to understand telomerase activity and its interactions with other cellular components. Patients may benefit from insights that could lead to new treatments for age-related conditions and cancers.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that address both aging-related diseases and cancer.

How similar studies have gone: Previous research has shown promising results in targeting telomerase for cancer treatment, indicating that this approach has potential for success.

Where this research is happening

  • Research Inst of Fox Chase Can Ctr
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Chen, Lu — Research Inst of Fox Chase Can Ctr
  • Study coordinator: Chen, Lu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.